BillionToOne drops after in-line quarter, maintains annual revenue outlook
BLLN•Revenue outlook maintained
The company maintained its annual revenue forecast at between $450.0 million and $465.0 million. Second-quarter revenue of $109.4 million was about in line with estimates.
BTIG said BillionToOne came into the second-quarter print "hot" and surprised investors with an in-line quarter. At least two brokerages cut their price targets on the company.
Up to the previous close, the stock was up 83% year to date.
Shares fall after quarterly results
Shares of molecular diagnostics company BillionToOne BLLN.O fell 25.95% to $111.06 in premarket trading after the company reported a quarter that was in line with expectations.
